BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35565658)

  • 1. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
    Miao X; Wu J; Chen H; Lu G
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
    Owings KG; Lowry JB; Bi Y; Might M; Chow CY
    Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
    Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
    J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved role for AMP-activated protein kinase in NGLY1 deficiency.
    Han SY; Pandey A; Moore T; Galeone A; Duraine L; Cowan TM; Jafar-Nejad H
    PLoS Genet; 2020 Dec; 16(12):e1009258. PubMed ID: 33315951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency.
    Hall PL; Lam C; Alexander JJ; Asif G; Berry GT; Ferreira C; Freeze HH; Gahl WA; Nickander KK; Sharer JD; Watson CM; Wolfe L; Raymond KM
    Mol Genet Metab; 2018 May; 124(1):82-86. PubMed ID: 29550355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
    Suzuki T
    J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISA-based highly sensitive assay system for the detection of endogenous NGLY1 activity.
    Fujihira H; Sato K; Nishiuchi Y; Murase T; Matsuda Y; Yoshida Y; Kamei T; Suzuki T
    Biochem Biophys Res Commun; 2024 May; 710():149826. PubMed ID: 38581946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplained death in patients with NGLY1 mutations may be explained by adrenal insufficiency.
    van Keulen BJ; Rotteveel J; Finken MJJ
    Physiol Rep; 2019 Feb; 7(3):e13979. PubMed ID: 30740912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a
    Rodriguez TP; Mast JD; Hartl T; Lee T; Sand P; Perlstein EO
    G3 (Bethesda); 2018 Jul; 8(7):2193-2204. PubMed ID: 29735526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: A case report and review of the literature.
    Sonoda Y; Fujita A; Torio M; Mukaino T; Sakata A; Matsukura M; Yonemoto K; Hatae K; Ichimiya Y; Chong PF; Ochiai M; Wada Y; Kadoya M; Okamoto N; Murakami Y; Suzuki T; Isobe N; Shigeto H; Matsumoto N; Sakai Y; Ohga S
    Eur J Med Genet; 2024 Feb; 67():104895. PubMed ID: 38070824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.
    Mueller WF; Jakob P; Sun H; Clauder-Münster S; Ghidelli-Disse S; Ordonez D; Boesche M; Bantscheff M; Collier P; Haase B; Benes V; Paulsen M; Sehr P; Lewis J; Drewes G; Steinmetz LM
    G3 (Bethesda); 2020 May; 10(5):1585-1597. PubMed ID: 32265286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Natural Compound Containing a Disaccharide Structure of Glucose and Rhamnose Identified as Potential N-Glycanase 1 (NGLY1) Inhibitors.
    Liu R; Gu J; Ye Y; Zhang Y; Zhang S; Lin Q; Yuan S; Chen Y; Lu X; Tong Y; Lv S; Chen L; Sun G
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of peptide:
    Yoshida Y; Asahina M; Murakami A; Kawawaki J; Yoshida M; Fujinawa R; Iwai K; Tozawa R; Matsuda N; Tanaka K; Suzuki T
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34215698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthopaedic phenotyping of NGLY1 deficiency using an international, family-led disease registry.
    Cahan EM; Frick SL
    Orphanet J Rare Dis; 2019 Jun; 14(1):148. PubMed ID: 31217022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of motor dysfunction in the rat model of NGLY1 deficiency.
    Asahina M; Fujinawa R; Hirayama H; Tozawa R; Kajii Y; Suzuki T
    Mol Brain; 2021 Jun; 14(1):91. PubMed ID: 34120625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid editing of NFE2L1 by PNGase causes abnormal mobility on SDS-PAGE.
    Tachida Y; Hirayama H; Suzuki T
    Biochim Biophys Acta Gen Subj; 2023 Dec; 1867(12):130494. PubMed ID: 37865174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.
    Mei S; Ayala R; Ramarathinam SH; Illing PT; Faridi P; Song J; Purcell AW; Croft NP
    Mol Cell Proteomics; 2020 Jul; 19(7):1236-1247. PubMed ID: 32357974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and biochemical studies of the C-terminal domain of mouse peptide-N-glycanase identify it as a mannose-binding module.
    Zhou X; Zhao G; Truglio JJ; Wang L; Li G; Lennarz WJ; Schindelin H
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17214-9. PubMed ID: 17088551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiency.
    Makita Y; Asahina M; Fujinawa R; Yukitake H; Suzuki T
    Commun Biol; 2024 Apr; 7(1):460. PubMed ID: 38649481
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.